Article
Effect of rotavirus genetic diversity on vaccine impact.
Reviews in medical virology - 1 Jan 2022
Sadiq Asma, Bostan Nazish, Jadoon Khan, Aziz Aamir
Abstract excerpt
Group A rotaviruses (RVAs) are the leading cause of gastroenteritis, causing 0.2 million deaths and several million hospitalisations globally each year. Four rotavirus vaccines (RotarixTM , RotaTeqTM , Rotavac® and ROTASIIL® ) have been pre-qualified by the World Health Organization (WHO), but the two newly pre-qualified vaccines (Rotavac® and ROTASIIL® ) are currently only in use in Palestine and India,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
